Rana McKay, MD, Medical Oncologist, Assistant Professor of Medicine, University of California, San Diego, Discusses TIVO-3 Study In Highly Refractory Advanced RCC Patients. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.
http://obroncology.com